Company performance
Add to research
Current Price
as of Jun 18, 2025$1.07
P/E Ratio
N/A
Market Cap
$4.68M
Description
Add to research
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Waltham, MA.
Metrics
Add to research
Overview
- HQWaltham, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerMBIO
- Price$1.07+4.90%
Trading Information
- Market cap$4.68M
- Float71.89%
- Average Daily Volume (1m)92,209
- Average Daily Volume (3m)412,400
- EPS-$20.65
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$0.15M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$0.21M
- EV-$10.65M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.00
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account